Expression of Oct4 in the CD44-positive tumor cells could also be detected, albeit in a small percentage, in the tissue slices of cisplatin-resistant TCCSUP tumor xenografts after cisplatin treatment (Figure 3C), suggesting a potential role for Oct4 in the poor response of tumors to cisplatin treatment. This evidence concerns the gene POU5F1 and neoplasm.